Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone

NCT01428219 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
25
Enrollment
OTHER
Sponsor class

Stopped Closed due to slowing enrollment and negative results of a phase III trial using cabozantinib.

Conditions

Interventions

Sponsor

University of Michigan Rogel Cancer Center

Collaborators